Abstract
Aims International diabetes guidelines have not established the frequencies of self‐monitoring of blood glucose in patients with type 2 diabetes (T2D) who do not use insulin. The present study aimed to assess the impact of SMBG frequencies on the glucose control and other outcomes in non‐insulin‐treated patients with T2D. Methods A literature search was performed in four databases. Randomised controlled trials with ≥ 6‐month follow‐up duration that compared the impact of different frequencies of SMBG on glycated haemoglobin A1c (HbA1c) were included. Studies with abstract only or reported effects of SMBG as a secondary outcome were excluded. Results Of the 1,557 studies identified, 12 RCTs with a total of 3,350 patients were analyzed. Overall, performing SMBG for 8 to 14 times per week was correlated with a better HbA1c control at six months (MD ‐0.46%, 95% CI ‐0.54 to ‐0.39) and 12 months (MD ‐0.20%, 95% CI ‐0.29 to ‐0.11). However, up to seven measurements of SMBG per week did not significantly affect glycemic control. In addition, performing SMBG between 8 and 14 times per week was also associated with improved BMI (MD ‐0.46, 95% CI ‐0.84 to ‐0.08). When the results of SMBG were applied to adjust diabetes medication, a significant reduction in HbA1c levels was observed in the intervention arm compared to the control arm. Conclusions 8 to 14 measurements of SMBG per week were associated with an improved glycemic control and a reduced BMI in patients with T2D not using insulin.

This publication has 40 references indexed in Scilit: